Abstract
This report:
- Describes the hormone replacement therapy (HRT) for different conditions
including menopause, cancer, Growth Hormone deficiency, Turner' s Syndrome,
Klinfelter' s Syndrome, osteoporosis and Alzheimer' s disease
- Includes a current market analysis and five-year market projections, from
2008 to 2013
- Discusses regulatory issues including new drug approvals
- Provides complete company profiles, competitive analysis, industry
structure, market shares, and patent analyses.
SCOPE OF REPORT
The scope of this study encompasses global markets for hormonal therapies. BCC
analyzes each market and its market leaders; different types of therapies; the
regulatory environment; the different disease sectors for the use of hormonal
therapies; and market projections and market share. Technological issues
include the latest trends and new developments.
METHODOLOGY
A comprehensive literature search was conducted. The literature included
technical newsletters and journals as well as many other sources. Data were
collected through interviews and correspondence with various
pharmaceutical/biotechnical experts. Projections were based on estimates such
as the current number of end users, potential end users, likely unit prices,
rates of consumption, and market trends.
INFORMATION SOURCES
BCC surveyed many companies to obtain data for this study. Included were
manufacturers and the end users of the cancer drugs. We gathered the data from
the industries; spoke with officials of this industry; and consulted
newsletters, company literature, product literature, a host of technical
articles, journals, indexes, and abstracts. Exhaustive investigations of
databases by key terminology were completed. In addition, data were compiled
from current financial and trade information and government sources.
ANALYST' s CREDENTIALS
Shalini Shahani Dewan holds a masters degree in pharmaceutical chemistry.
Among the research topics she has covered are studies on compounds of
potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid.
Shahani was awarded a gold medal by the prime minister of India for her work
and has worked with top companies in India and in the U.S. Some of her other
reports with BCC include Reagents of Chromatography; Spectroscopy: An Enduring
Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and
Devices; Imaging Reagents; Contract Manufacturing, Research and Packaging; The
Dynamic Media, Sera and Reagent market in Biotechnology; Opportunities in
Chiral Technology; Behavioral and Emotional Disorders in Children and
Adolescents; and Pharmaceutical Regulatory Industry, and many more.
View Cart
